Global Opioids Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 24-Jan-2023
No. of pages: 97

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others.

The report focuses on the Opioids Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Opioids Drugs market.

Major Players in the Opioids Drugs market are:

Sanofi-aventis US LLC

Johnson & Johnson

Orexo Pharmaceuticals

Endo Pharmaceuticals

Pfizer

Teva pharmaceuticals

Purdue Pharma

Hospira

AbbVie

Allergan

On the basis of types, the Opioids Drugs market is primarily split into:

Oxycodone (e.g., OxyContin, Percocet)

Hydrocodone (e.g., Vicodin)

Codeine

Morphine (e.g., Kadian, Avinza)

Others

On the basis of applications, the market covers:

Neuropathic pain treatment

Orthopedic pain treatment

Other pain treatment

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Opioids Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Opioids Drugs Market Overview
1.1 Product Overview and Scope of Opioids Drugs Market
1.2 Opioids Drugs Market Segment by Type
1.2.1 Global Opioids Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Opioids Drugs Market Segment by Application
1.3.1 Opioids Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Opioids Drugs Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Opioids Drugs (2017-2029)
1.5.1 Global Opioids Drugs Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Opioids Drugs Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Opioids Drugs Industry
1.7 Impact of Carbon Neutrality on the Opioids Drugs Industry

2 Opioids Drugs Market Upstream and Downstream Analysis
2.1 Opioids Drugs Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Opioids Drugs Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Sanofi-aventis US LLC
3.1.1 Sanofi-aventis US LLC Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Opioids Drugs Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Johnson & Johnson
3.2.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Opioids Drugs Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Orexo Pharmaceuticals
3.3.1 Orexo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Opioids Drugs Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Endo Pharmaceuticals
3.4.1 Endo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Opioids Drugs Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Pfizer
3.5.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Opioids Drugs Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Teva pharmaceuticals
3.6.1 Teva pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Opioids Drugs Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Purdue Pharma
3.7.1 Purdue Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Opioids Drugs Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Hospira
3.8.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Opioids Drugs Market Performance (2017-2022)
3.8.4 Business Overview
3.9 AbbVie
3.9.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Opioids Drugs Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Allergan
3.10.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Opioids Drugs Market Performance (2017-2022)
3.10.4 Business Overview

4 Global Opioids Drugs Market Landscape by Player
4.1 Global Opioids Drugs Sales and Share by Player (2017-2022)
4.2 Global Opioids Drugs Revenue and Market Share by Player (2017-2022)
4.3 Global Opioids Drugs Average Price by Player (2017-2022)
4.4 Global Opioids Drugs Gross Margin by Player (2017-2022)
4.5 Opioids Drugs Market Competitive Situation and Trends
4.5.1 Opioids Drugs Market Concentration Rate
4.5.2 Opioids Drugs Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Opioids Drugs Sales, Revenue, Price Trend by Type
5.1 Global Opioids Drugs Sales and Market Share by Type (2017-2022)
5.2 Global Opioids Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Opioids Drugs Price by Type (2017-2022)
5.4 Global Opioids Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Opioids Drugs Sales, Revenue and Growth Rate of Oxycodone (e.g., OxyContin, Percocet) (2017-2022)
5.4.2 Global Opioids Drugs Sales, Revenue and Growth Rate of Hydrocodone (e.g., Vicodin) (2017-2022)
5.4.3 Global Opioids Drugs Sales, Revenue and Growth Rate of Codeine (2017-2022)
5.4.4 Global Opioids Drugs Sales, Revenue and Growth Rate of Morphine (e.g., Kadian, Avinza) (2017-2022)
5.4.5 Global Opioids Drugs Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Opioids Drugs Market Analysis by Application
6.1 Global Opioids Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Opioids Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Opioids Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Opioids Drugs Consumption and Growth Rate of Neuropathic pain treatment (2017-2022)
6.3.2 Global Opioids Drugs Consumption and Growth Rate of Orthopedic pain treatment (2017-2022)
6.3.3 Global Opioids Drugs Consumption and Growth Rate of Other pain treatment (2017-2022)

7 Global Opioids Drugs Sales and Revenue Region Wise (2017-2022)
7.1 Global Opioids Drugs Sales and Market Share, Region Wise (2017-2022)
7.2 Global Opioids Drugs Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Opioids Drugs Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Opioids Drugs Market Forecast (2022-2029)
8.1 Global Opioids Drugs Sales, Revenue Forecast (2022-2029)
8.1.1 Global Opioids Drugs Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Opioids Drugs Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Opioids Drugs Price and Trend Forecast (2022-2029)
8.2 Global Opioids Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Opioids Drugs Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Opioids Drugs Sales and Revenue Forecast (2022-2029)
8.2.3 China Opioids Drugs Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Opioids Drugs Sales and Revenue Forecast (2022-2029)
8.2.5 India Opioids Drugs Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Opioids Drugs Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Opioids Drugs Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Opioids Drugs Sales and Revenue Forecast (2022-2029)
8.3 Global Opioids Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Opioids Drugs Revenue and Growth Rate of Oxycodone (e.g., OxyContin, Percocet) (2022-2029)
8.3.2 Global Opioids Drugs Revenue and Growth Rate of Hydrocodone (e.g., Vicodin) (2022-2029)
8.3.3 Global Opioids Drugs Revenue and Growth Rate of Codeine (2022-2029)
8.3.4 Global Opioids Drugs Revenue and Growth Rate of Morphine (e.g., Kadian, Avinza) (2022-2029)
8.3.5 Global Opioids Drugs Revenue and Growth Rate of Others (2022-2029)
8.4 Global Opioids Drugs Consumption Forecast by Application (2022-2029)
8.4.1 Global Opioids Drugs Consumption Value and Growth Rate of Neuropathic pain treatment (2022-2029)
8.4.2 Global Opioids Drugs Consumption Value and Growth Rate of Orthopedic pain treatment (2022-2029)
8.4.3 Global Opioids Drugs Consumption Value and Growth Rate of Other pain treatment (2022-2029)
8.5 Opioids Drugs Market Forecast Under COVID-19

9 Industry Outlook
9.1 Opioids Drugs Market Drivers Analysis
9.2 Opioids Drugs Market Restraints and Challenges
9.3 Opioids Drugs Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Opioids Drugs Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Opioids Drugs Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Opioids Drugs Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs